BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35468361)

  • 1. The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4
    Melderis S; Warkotsch MT; Dang J; Hagenstein J; Ehnold LI; Herrnstadt GR; Niehus CB; Feindt FC; Kylies D; Puelles VG; Berasain C; Avila MA; Neumann K; Tiegs G; Huber TB; Tharaux PL; Steinmetz OM
    J Autoimmun; 2022 May; 129():102829. PubMed ID: 35468361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphiregulin Aggravates Glomerulonephritis
    Melderis S; Hagenstein J; Warkotsch MT; Dang J; Herrnstadt GR; Niehus CB; Neumann K; Panzer U; Berasain C; Avila MA; Tharaux PL; Tiegs G; Steinmetz OM
    J Am Soc Nephrol; 2020 Sep; 31(9):1996-2012. PubMed ID: 32616537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis.
    Gartshteyn Y; Geraldino-Pardilla L; Khalili L; Bukhari S; Lerrer S; Winchester RJ; Askanase AD; Mor A
    Front Immunol; 2024; 15():1327437. PubMed ID: 38550577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ST2
    Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K
    Front Immunol; 2024; 15():1351405. PubMed ID: 38571949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RORγt expression in T
    Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
    Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.
    Santamaría E; Rodríguez-Ortigosa CM; Uriarte I; Latasa MU; Urtasun R; Alvarez-Sola G; Bárcena-Varela M; Colyn L; Arcelus S; Jiménez M; Deutschmann K; Peleteiro-Vigil A; Gómez-Cambronero J; Milkiewicz M; Milkiewicz P; Sangro B; Keitel V; Monte MJ; Marin JJG; Fernández-Barrena MG; Ávila MA; Berasain C
    Hepatology; 2019 Apr; 69(4):1632-1647. PubMed ID: 30411380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling.
    Liang CL; Lu W; Zhou JY; Chen Y; Zhang Q; Liu H; Qiu F; Dai Z
    Cell Physiol Biochem; 2018; 50(4):1560-1573. PubMed ID: 30359968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiregulin/epidermal growth factor receptor/hypoxia-inducible factor-1α pathway regulates T helper 9 and T cytotoxic 9 cell response in adult patients with infectious mononucleosis.
    Li Y; Li L; Zhang W; Gao Y
    Biomol Biomed; 2023 Feb; 23(1):63-72. PubMed ID: 36154925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalities.
    Yap DY; Lai KN
    Int J Mol Sci; 2015 Apr; 16(4):7917-31. PubMed ID: 25860947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiregulin in infectious diseases: Role, mechanism, and potential therapeutic targets.
    Hsu CY; Faisal Mutee A; Porras S; Pineda I; Ahmed Mustafa M; J Saadh M; Adil M; H A Z
    Microb Pathog; 2024 Jan; 186():106463. PubMed ID: 38036111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis.
    Wang S; Zhang Y; Wang Y; Ye P; Li J; Li H; Ding Q; Xia J
    J Biol Chem; 2016 Sep; 291(40):21085-21095. PubMed ID: 27432879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis.
    Savage TM; Fortson KT; de Los Santos-Alexis K; Oliveras-Alsina A; Rouanne M; Rae SS; Gamarra JR; Shayya H; Kornberg A; Cavero R; Li F; Han A; Haeusler RA; Adam J; Schwabe RF; Arpaia N
    Immunity; 2024 Feb; 57(2):303-318.e6. PubMed ID: 38309273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphiregulin in cellular physiology, health, and disease: Potential use as a biomarker and therapeutic target.
    Singh SS; Chauhan SB; Kumar A; Kumar S; Engwerda CR; Sundar S; Kumar R
    J Cell Physiol; 2022 Feb; 237(2):1143-1156. PubMed ID: 34698381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chorionic gonadotropin-induced amphiregulin stimulates aromatase expression in human granulosa-lutein cells: a mechanism for estradiol production in the luteal phase.
    Fang L; Yu Y; Li Y; Wang S; Zhang R; Guo Y; Li Y; Yan Y; Sun YP
    Hum Reprod; 2019 Oct; 34(10):2018-2026. PubMed ID: 31553790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4
    Mesquita D; Kirsztajn GM; Franco MF; Reis LA; Perazzio SF; Mesquita FV; Ferreira VDS; Andrade LEC; de Souza AWS
    Clin Exp Immunol; 2018 Jan; 191(1):50-59. PubMed ID: 28945272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal-infiltrating CD11c
    Liao X; Ren J; Reihl A; Pirapakaran T; Sreekumar B; Cecere TE; Reilly CM; Luo XM
    Clin Exp Immunol; 2017 Nov; 190(2):187-200. PubMed ID: 28722110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.
    Raimondo S; Saieva L; Vicario E; Pucci M; Toscani D; Manno M; Raccosta S; Giuliani N; Alessandro R
    J Hematol Oncol; 2019 Jan; 12(1):2. PubMed ID: 30621731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphiregulin increases migration and proliferation of epithelial ovarian cancer cells by inducing its own expression via PI3-kinase signaling.
    Bolitho C; Moscova M; Baxter RC; Marsh DJ
    Mol Cell Endocrinol; 2021 Aug; 533():111338. PubMed ID: 34062166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
    Schaier M; Gottschalk C; Uhlmann L; Speer C; Kälble F; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
    Arthritis Res Ther; 2018 Dec; 20(1):278. PubMed ID: 30563559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
    Rafael-Vidal C; Altabás I; Pérez N; Mourino Rodríguez C; Pego-Reigosa JM; Garcia S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.